A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE3
The purpose of this study is to evaluate the efficacy and safety of \*\*Dis...
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
PHASE3
The purpose of this study is to evaluate the efficacy and safety of Disitam...
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
PHASE2
The efficacy and safety of combination with Disitamab Vedotin and with Tisl...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital